Live Updates: COVID-19 Cases
  • World 20,141,343
    World
    Confirmed: 20,141,343
    Active: 6,416,055
    Recovered: 12,989,244
    Death: 736,044
  • USA 5,216,313
    USA
    Confirmed: 5,216,313
    Active: 2,376,652
    Recovered: 2,673,846
    Death: 165,815
  • Brazil 3,039,349
    Brazil
    Confirmed: 3,039,349
    Active: 819,620
    Recovered: 2,118,460
    Death: 101,269
  • India 2,266,954
    India
    Confirmed: 2,266,954
    Active: 641,333
    Recovered: 1,580,269
    Death: 45,352
  • Russia 892,654
    Russia
    Confirmed: 892,654
    Active: 180,972
    Recovered: 696,681
    Death: 15,001
  • South Africa 559,859
    South Africa
    Confirmed: 559,859
    Active: 137,977
    Recovered: 411,474
    Death: 10,408
  • Mexico 480,278
    Mexico
    Confirmed: 480,278
    Active: 105,515
    Recovered: 322,465
    Death: 52,298
  • Peru 478,024
    Peru
    Confirmed: 478,024
    Active: 132,932
    Recovered: 324,020
    Death: 21,072
  • Chile 375,044
    Chile
    Confirmed: 375,044
    Active: 17,563
    Recovered: 347,342
    Death: 10,139
  • Spain 361,442
    Spain
    Confirmed: 361,442
    Active: 332,939
    Recovered: ?
    Death: 28,503
  • Iran 328,844
    Iran
    Confirmed: 328,844
    Active: 23,586
    Recovered: 286,642
    Death: 18,616
  • UK 311,641
    UK
    Confirmed: 311,641
    Active: 265,115
    Recovered: ?
    Death: 46,526
  • Saudi Arabia 289,947
    Saudi Arabia
    Confirmed: 289,947
    Active: 33,270
    Recovered: 253,478
    Death: 3,199
  • Pakistan 284,660
    Pakistan
    Confirmed: 284,660
    Active: 17,799
    Recovered: 260,764
    Death: 6,097
  • Bangladesh 260,507
    Bangladesh
    Confirmed: 260,507
    Active: 106,632
    Recovered: 150,437
    Death: 3,438
  • Italy 250,825
    Italy
    Confirmed: 250,825
    Active: 13,368
    Recovered: 202,248
    Death: 35,209
  • Turkey 240,804
    Turkey
    Confirmed: 240,804
    Active: 11,201
    Recovered: 223,759
    Death: 5,844
  • Germany 217,563
    Germany
    Confirmed: 217,563
    Active: 10,403
    Recovered: 197,900
    Death: 9,260
  • France 197,921
    France
    Confirmed: 197,921
    Active: 84,761
    Recovered: 82,836
    Death: 30,324
  • Canada 119,723
    Canada
    Confirmed: 119,723
    Active: 4,755
    Recovered: 105,986
    Death: 8,982
  • China 84,668
    China
    Confirmed: 84,668
    Active: 802
    Recovered: 79,232
    Death: 4,634
  • Netherlands 59,194
    Netherlands
    Confirmed: 59,194
    Active: 53,037
    Recovered: ?
    Death: 6,157
  • Australia 21,407
    Australia
    Confirmed: 21,407
    Active: 9,217
    Recovered: 11,876
    Death: 314
  • S. Korea 14,626
    S. Korea
    Confirmed: 14,626
    Active: 663
    Recovered: 13,658
    Death: 305
  • New Zealand 1,569
    New Zealand
    Confirmed: 1,569
    Active: 21
    Recovered: 1,526
    Death: 22

MIT researchers develop antibody-like receptor proteins to treat COVID-19

Author at TechGenyz Science
Cytokine Storm For COVID-19
Cytokine Storm For COVID-19 Cases

A team of MIT researches has developed a specialized protein that has the ability to soak up the excessive immune response that occurs in severe cases for COVID-19.

“The idea is that they can be injected into the body and bind to the excessive cytokines as generated by the cytokine storm, removing the excessive cytokines and alleviating the symptoms from the infection,” says Rui Qing, an MIT research scientist who is one of the senior authors of the study. Shilei Hao is the lead author of the study, Shuguang Zhang is a senior author of the paper, and David Jin is also an author.

The researchers are hoping that they can start testing the proteins on human cells and in animal models of cytokine release and coronavirus infection.

Zhang began working on this project ten years ago, and it was focused on developing a modified version of membrane-embedded proteins. Jin later approached Zhang’s lab. Jin believed that proteins that mimic the cytokine receptors could help combat cytokine storms. Zhang’s team began designing proteins that could mop up the excessive cytokines in April 2019. Zhang’s team used a hydrophilic version of the protein that could travel easily through the human bloodstream. “The cytokine receptors that we designed will soak up the majority of the excessive cytokines that are released during the cytokine storm,” Jin says.

To further stabilize the proteins in the bloodstream, the team attached an antibody segment called the Fc region. The inclusion of the Fc region makes sure that they are not attacked by the immune system.

The study gained momentum post-March when the evidence began to suggest that the SARS-CoV-2 virus was inducing cytokine storms in some patients, and the receptor proteins could be of help.

“As it turns out, our research initiated in April 2019 is directly relevant to the treatment of COVID-19 infected patients,” Zhang said, “Curiosity-driven, or even proactive research often leads to preparedness, which is key to preventing future disasters.”

The team is confident that this discovery will contribute further to clinical applications in treating viral diseases.

Career

Subscribe